Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-12-02

FDA Approved: BROMFENAC OPHTHALMIC SOLUTION — Supplemental Application (Bausch & Lomb Americas Inc.)

View source ↗

Summary

FDA approved a supplemental application for Bromfenac Ophthalmic Solution by Bausch & Lomb Americas, updating labeling to reflect postoperative ocular pain and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromfenac Ophthalmic Solution (bromfenac sodium)

Snippet

SUPPL AP for BROMFENAC OPHTHALMIC SOLUTION (BROMFENAC SODIUM)